ONCOCLEW
LIVE

Serial Number

79346461

Owner

SG MEDICAL, INC.

Attorney

Kisuk Lee

Filing Date

Apr 28, 2022

Add to watchlist:

No watchlists yet
View on USPTO

ONCOCLEW Trademark

Serial Number: 79346461 • Registration: 7265304

ONCOCLEW is a trademark filed by SG MEDICAL, INC. on April 28, 2022. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

SG MEDICAL, INC. (7 trademarks)

3-11, Ogeum-ro 13-gil,

Entity Type: 03

ONCOCLEW CO., LTD.

Songpa-gu Seoul 05505

Entity Type: 99

Trademark Details

Filing Date

April 28, 2022

Registration Date

January 9, 2024

Published for Opposition

October 24, 2023

Goods & Services

Business administration; business administration and management; business management and administration; business management

Medical services, namely, analysis of human biodata for medical purposes; providing information in the field of medicine

Conducting early evaluations in the field of new pharmaceuticals; drug discovery services; pharmaceutical drug development services; inspection of pharmaceuticals for quality control purposes; development of pharmaceutical preparations and medicines; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; laboratory research in the field of pharmaceuticals; pharmaceutical research and development; research relating to pharmaceuticals; services for assessing the efficiency of pharmaceuticals, namely, testing of pharmaceuticals; scientific research in the field of pharmacology; medical laboratory services, namely, preparing and preserving tissue samples for use by others for medical research purposes; medicine research; product development consultation, namely, analysis and evaluation of medical product development; pharmaceutical product evaluation; medical and pharmacological research services; medical laboratory services, namely, performing biopsies for medical research; analysis of human tissues for medical research

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
May 21, 2024 FINO
CHANGE OF OWNER RECEIVED FROM IB
May 11, 2024 CHLD
FINAL DISPOSITION NOTICE SENT TO IB
Apr 10, 2024 FICS
FINAL DISPOSITION PROCESSED
Apr 10, 2024 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 9, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 9, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Jan 9, 2024 R.PR
NOTIFICATION PROCESSED BY IB
Oct 24, 2023 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 24, 2023 NPUB
PUBLISHED FOR OPPOSITION
Oct 24, 2023 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Oct 4, 2023 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Oct 4, 2023 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 4, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 18, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
Aug 30, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 30, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Aug 30, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 30, 2023 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 24, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 23, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 23, 2023 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 23, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 23, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 23, 2023 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Aug 23, 2023 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Aug 23, 2023 COAR
REFUSAL PROCESSED BY IB
May 2, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 13, 2023 RFCS
REFUSAL PROCESSED BY MPU
Apr 13, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 23, 2023 RFCR
NON-FINAL ACTION WRITTEN
Feb 22, 2023 CNRT
ASSIGNED TO EXAMINER
Feb 16, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Aug 9, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 5, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 4, 2022 REPR